Sofosbuvir Enrolling by Invitation Phase N/A Trials for Hepatitis C Virus Infection

IndicationsStatusPurposePhase
Enrolling by InvitationNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02510300A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials